Mumbai (Maharashtra) [India], July 1: For many women facing fertility challenges, conditions like Polycystic Ovary Syndrome (PCOS) and Premature Ovarian Insufficiency (POI) can make the path to pregnancy complex and uncertain. But with modern science, expert care, and tailored treatment plans, hope is very much alive.
At the forefront of this progress is Dr. Hrishikesh Pai — a globally acclaimed fertility expert, founder of Bloom IVF, and a leading IVF doctor in Mumbai, India — whose pioneering hormone-based strategies are helping more women overcome these reproductive hurdles.
“PCOS and POI are two of the most common yet distinct causes of infertility we encounter in clinical practice,” explains Dr. Pai. “Both conditions impact ovarian function — but in different ways. The key to success lies in understanding a woman’s individual hormone profile, especially her Follicle-Stimulating Hormone (FSH) levels. These insights allow us to design treatment protocols that optimize egg quality, response to stimulation, and ultimately, pregnancy outcomes.”
FSH — produced by the pituitary gland — plays a vital role in the maturation of ovarian follicles, which contain eggs. In PCOS, women typically have a high number of small follicles, but hormonal imbalances can disrupt ovulation. In contrast, POI is marked by diminished ovarian reserve and elevated FSH levels, signalling poor follicle responsiveness.
“By carefully analyzing FSH trends — alongside other markers like AMH (Anti-Müllerian Hormone) and estradiol — we gain a dynamic picture of how a woman’s ovaries will respond to IVF stimulation,” says Dr. Pai.
In women with PCOS, Dr. Pai employs low-dose gonadotropin stimulation protocols combined with precise cycle monitoring. This approach minimizes the risk of Ovarian Hyperstimulation Syndrome (OHSS), a serious complication commonly associated with PCOS. In addition, medications like letrozole may be used to promote more physiological follicular growth.
“PCOS is not an insurmountable barrier,” Dr. Pai emphasizes. “With a gentle, hormone-informed approach, we can safely retrieve high-quality eggs and achieve excellent success rates.”
For patients with POI — often diagnosed before the age of 40 — the challenge is greater. Elevated FSH levels indicate a diminished ovarian reserve, and IVF outcomes can be unpredictable. However, Dr. Pai’s advanced protocols, developed through decades of research, have helped many women with POI achieve pregnancy. These include the use of androgen or growth hormone pre-treatment, individualized stimulation regimens, and, where appropriate, counselling on the option of using donor eggs.
“The goal is always to offer the best path to a healthy baby — whether through a woman’s own eggs or with the assistance of donor programme,” Dr. Pai explains.
One recent patient success story illustrates this personalized, hormone-based approach. A 34-year-old woman with PCOS and multiple failed IVF cycles elsewhere came to Bloom IVF with an AMH of 8 ng/mL and normal FSH, but with irregular ovulation and prior episodes of OHSS. Dr. Pai’s team employed a low-dose antagonist protocol with a GnRH agonist trigger, carefully avoiding OHSS. Fourteen mature oocytes were retrieved, resulting in 10 high-quality embryos. A single euploid embryo was transferred — leading to a successful pregnancy.
In another case, a 37-year-old woman diagnosed with POI and an FSH of 20 mIU/mL had been advised by other clinics to consider egg donation. However, after a comprehensive evaluation by Dr. Pai’s team — including Doppler ultrasound assessment of ovarian blood flow — a tailored stimulation cycle was attempted. Two mature oocytes were retrieved, one high-grade embryo was developed, and the patient is now 10 weeks pregnant following frozen embryo transfer.
“This is why we leave no stone unturned,” says Dr. Pai. “Sometimes, even one good egg can make the difference.”
India faces a growing fertility crisis, with approximately 1 in 6 couples experiencing infertility. PCOS affects an estimated 10–15% of Indian women of reproductive age, while POI is increasingly recognized as an underdiagnosed contributor to infertility. Despite these challenges, Dr. Pai remains optimistic.
“Our ability to personalize IVF using hormone insights has never been better. With advanced diagnostics and science-based protocols, we’re giving many women new hope — even in difficult cases.”
As Medical Director of Bloom IVF, which operates 11 world-class fertility centres across India, Dr. Pai is committed to advancing reproductive medicine through innovation and compassion. His leadership in introducing technologies like IMSI, laser-assisted hatching, and vitrification to India — combined with his expertise in hormonal modulation — has earned him international accolades, including the ISAR Lifetime Achievement Award and the Fellowship of the Royal College of Obstetricians and Gynaecologists, UK.
For women facing PCOS, POI, or other fertility challenges, knowledge is power.
“Understanding your hormone profile is not just diagnostic — it’s foundational to smarter, more effective reproductive care,” Dr. Pai concludes. “With the right insights and the right team, even complex journeys can lead to joyful outcomes.”
To learn more about IVF treatment for PCOS and POI, or to schedule a consultation with Dr. Hrishikesh Pai, visit:
Babies & Us Fertility IVF & ICSI Center
OPERA HOUSE, MUMBAI, 534, 4th Floor, Bombay Mutual Terrace Opera House, Mumbai 400004
+91-98717 17305
About Dr. Hrishikesh Pai:
Dr. Hrishikesh Pai is one of India’s most respected IVF specialists, with 40+ years of experience in infertility, gynecology, and assisted reproduction. As founder of Bloom IVF, he leads one of India’s top fertility networks, delivering world-class care for complex reproductive conditions with precision, compassion, and a commitment to global standards of excellence.
